ID: ALA1963156

Max Phase: Preclinical

Molecular Formula: C19H22N4O

Molecular Weight: 322.41

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN1CCC(c2c[nH]c3ccc(/N=C(\N)c4ccco4)cc23)CC1

Standard InChI:  InChI=1S/C19H22N4O/c1-23-8-6-13(7-9-23)16-12-21-17-5-4-14(11-15(16)17)22-19(20)18-3-2-10-24-18/h2-5,10-13,21H,6-9H2,1H3,(H2,20,22)

Standard InChI Key:  DUYGYKLNIICLLA-UHFFFAOYSA-N

Associated Targets(Human)

Nitric-oxide synthase, brain 1786 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Nitric oxide synthase, inducible 1636 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Nitric-oxide synthase, endothelial 1452 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

5-hydroxytryptamine 1D receptor 16 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 322.41Molecular Weight (Monoisotopic): 322.1794AlogP: 3.61#Rotatable Bonds: 3
Polar Surface Area: 70.55Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.14CX LogP: 2.59CX LogD: 0.84
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.57Np Likeness Score: -0.86

References

1.  (2013)  Substituted indole compounds having NOS inhibitory activity, 

Source

Source(1):